Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

No Gender Differences in Long-Term Survival after Brachytherapy of 1,541 Patients with Uveal Melanoma.

Stålhammar G, See TR, Filì M, Seregard S.

Ocul Oncol Pathol. 2019 Oct;5(6):432-439. doi: 10.1159/000497186. Epub 2019 Mar 19.

PMID:
31768367
3.

Digital Image Analysis of BAP-1 Accurately Predicts Uveal Melanoma Metastasis.

Stålhammar G, See TRO, Phillips S, Seregard S, Grossniklaus HE.

Transl Vis Sci Technol. 2019 May 6;8(3):11. doi: 10.1167/tvst.8.3.11. eCollection 2019 May.

4.

Neurothekeoma of the eye, conjunctiva, and periorbital adnexa: A report of two cases and brief review.

See TRO, Stålhammar G, Grossniklaus HE.

Surv Ophthalmol. 2019 Nov - Dec;64(6):852-857. doi: 10.1016/j.survophthal.2019.04.002. Epub 2019 Apr 9. Review.

PMID:
30978337
5.

Ruthenium-106 versus iodine-125 plaque brachytherapy of 571 choroidal melanomas with a thickness of ≥5.5 mm.

Filì M, Trocme E, Bergman L, See TRO, André H, Bartuma K, Girnita L, All-Eriksson C, Seregard S, Stålhammar G.

Br J Ophthalmol. 2019 Mar 25. pii: bjophthalmol-2018-313419. doi: 10.1136/bjophthalmol-2018-313419. [Epub ahead of print]

PMID:
30910871
6.

Comparison of histologic findings in age-related macular degeneration with RPE flatmount images.

Zhang Q, Chrenek MA, Bhatia S, Rashid A, Ferdous S, Donaldson KJ, Skelton H, Wu W, See TRO, Jiang Y, Dalal N, Nickerson JM, Grossniklaus HE.

Mol Vis. 2019 Feb 7;25:70-78. eCollection 2019.

Supplemental Content

Support Center